Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Guangxi Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 19 active clinical trials for multiple myeloma hosted across 11 tertiary medical centers in Guangxi (including The First Affiliated Hospital of Guangxi Medical University, People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Medical University Cancer Hospital, etc.).
Participating Medical Centers (11)
Active Studies in Guangxi (19)
Population synthesized by CMDNShowing 0 published English records of 19 registry trials.
All 19 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.